Reproducibility of risk figures in 2nd-trimester maternal serum screening for Down syndrome: Comparison of 2 laboratories

Clinical Chemistry

Volumn 52, Issue 11, 2006, Pages 2087-2094

  Benn, Peter A ^a   Makowski, Gregory S ^a,c   Egan, James F X ^a   Wright, Dave ^b  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b UNIVERSITY OF PLYMOUTH   (United Kingdom)

^c HARTFORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL; INHIBIN A;

ADULT; ALGORITHM; ANALYTICAL ERROR; ARTICLE; CALCULATION; COMPUTER MODEL; DIAGNOSTIC ACCURACY; DOWN SYNDROME; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MATERNAL SERUM; MONTE CARLO METHOD; REPRODUCIBILITY; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY; STATISTICAL SIGNIFICANCE;

ADULT; BIOLOGICAL MARKERS; DIAGNOSTIC ERRORS; DOWN SYNDROME; FEMALE; HUMANS; MONTE CARLO METHOD; MOTHERS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS;

EID: 33750474871     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2006.068783     Document Type: Article

References (25)

1. Benn PA. Advances in prenatal screening for Down syndrome: I general principles and second trimester testing. Clin Chim Acta 2002;323:1-16.
2. Benn PA. Advances in prenatal screening for Down syndrome: II first trimester testing and future directions. Clin Chim Acta 2002;324:1-11.
3. Haddow JE, Palomaki GE. Prenatal screening for Down syndrome. In: Simpson JL, Elias S, eds. Essentials of Prenatal Diagnosis. New York: Churchill Livingstone, 1993:185-220.
4. Reynolds TM, Penny MD. The mathematical basis of multivariate risk screening: with special reference to screening for Down syndrome associated pregnancy. Ann Clin Biochem 1989;27:452-8.
5. Cuckle H. Established markers in second trimester maternal serum. Early Hum Dev 1996;47:S27-9.
6. Wald NJ, Huttly WJ. Validation of risk estimation using the quadruple test in prenatal screening for Down syndrome. Prenat Diagn 1999;19:1083-4.
7. Canick JA, Rish S. The accuracy of assigned risks in maternal serum screening [Letter]. Prenat Diagn 1998;18:413-5.
8. Benn PA, Collins R. Evaluation of analytical precision in maternal serum screening for Down syndrome. Ann Clin Biochem 2001;38:28-36.
9. Ellis AR. Antenatal screening for Down syndrome - can we do better? Ann Clin Biochem 1993;30:421-4.
10. College of Pathologists. FBR/CAP Maternal Serum Screening Reports. Northfield, IL, College of Pathologists, 2005.
11. Chen J, Heffley D, Beazoglou T, Benn PA. Utilization of amniocentesis by women screen-positive for Down syndrome by the second trimester triple test. Commun Genet 2000;3:24-30.
12. Lambert-Messerlian GM, Eklund EE, Malone FD, Palomaki GE, Canick JA, D'Alton ME. Stability of first- and second-trimester serum markers after storage and shipment. Prenat Diagn 2006;26:17-21.
13. Wald NJ, Cuckle H, Brock JH, Peto R, Polani PE, Woodford FP. Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of U.K. collaborative study on alpha-fetoprotein in relation to neural-tube defects. Lancet 1977;1:1323-32.
14. Haddow JE, Palomaki GE, Knight GJ, Canick JA, eds. Prenatal Screening for Major Fetal Disorders. Vol II. Down's Syndrome. Scarborough, ME: Foundation for Blood Research, 1998.
15. Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Royston P, Chard T, et al. Maternal serum screening for Down's syndrome in early pregnancy. BMJ 1988;297:883-7.
16. Watt HC, Wald NJ, Huttly WJ. The pattern of maternal serum inhibin-A concentrations in the second trimester of pregnancy. Prenat Diagn 1998;18:846-8.
17. Wald NJ, Densem JW, Smith D, Klee GG. Four-marker serum screening for Down's syndrome. Prenat Diagn 1994;14:707-16.
18. Wald NJ, Densem JW, George L, Muttukrishna S, Knight PG. Prenatal screening for Down's syndrome using inhibin-A as a serum marker. Prenat Diagn 1996;16:143-52.
19. Erratum Prenat Diagn 1997;17:285-90.
20. Wald NJ, Hackshaw AK, George LM. Assay precision of serum α fetoprotein in antenatal screening for neural tube defects and Down's syndrome. J Med Screen 2000;7:74-7.
21. Cuckle HS. Updated modeling parameters for Down's syndrome screening. Balkan J Med Genet 2003;6:101-7.
22. Cuckle H. Improving parameters for risk estimation in Down's syndrome screening. Prenat Diagn 1995;15:1057-65.
23. National Center for Health Statistics. Vital Statistics of the United States, 2000: Natility Data Set. CD ROM, Series 21, 14, Hyattsville, MD, 2004.
24. Benn PA, Fang M, Egan JFX, Home D, Collins R. Incorporation of Inhibin-A in second-trimester screening for Down syndrome. Obstet Gynecol 2003;101:451-4.
25. Benn PA, Wright D, Cuckle H. Practical strategies in contingent sequential screening for Down syndrome. Prenat Diagn 2005;25:645-52.